Literature DB >> 21667288

Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.

Tihomir Tomašić1, Andreja Kovač, Gerhard Klebe, Didier Blanot, Stanislav Gobec, Danijel Kikelj, Lucija Peterlin Mašič.   

Abstract

Mur ligases are bacterial enzymes involved in the cytoplasmic steps of peptidoglycan biosynthesis and are viable targets for antibacterial drug discovery. We have performed virtual screening for potential ATP-competitive inhibitors targeting MurC and MurD ligases, using a protocol of consecutive hierarchical filters. Selected compounds were evaluated for inhibition of MurC and MurD ligases, and weak inhibitors possessing dual inhibitory activity have been identified. These compounds represent new scaffolds for further optimisation towards multiple Mur ligase inhibitors with improved inhibitory potency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667288     DOI: 10.1007/s00894-011-1139-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  43 in total

1.  Role of the ortholog and paralog amino acid invariants in the active site of the UDP-MurNAc-L-alanine:D-glutamate ligase (MurD).

Authors:  A Bouhss; S Dementin; C Parquet; D Mengin-Lecreulx; J A Bertrand; D Le Beller; O Dideberg; J van Heijenoort; D Blanot
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

Review 3.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

Review 4.  ATP-binding site of bacterial enzymes as a target for antibacterial drug design.

Authors:  Veronika Škedelj; Tihomir Tomašić; Lucija Peterlin Mašič; Anamarija Zega
Journal:  J Med Chem       Date:  2011-01-14       Impact factor: 7.446

5.  Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc:L-alanine ligase from Escherichia coli.

Authors:  A Bouhss; D Mengin-Lecreulx; D Blanot; J van Heijenoort; C Parquet
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

6.  Determination of the MurD mechanism through crystallographic analysis of enzyme complexes.

Authors:  J A Bertrand; G Auger; L Martin; E Fanchon; D Blanot; D Le Beller; J van Heijenoort; O Dideberg
Journal:  J Mol Biol       Date:  1999-06-11       Impact factor: 5.469

7.  Structure of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC).

Authors:  Taru Deva; Edward N Baker; Christopher J Squire; Clyde A Smith
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-11-23

8.  Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion.

Authors:  M S Anderson; S S Eveland; H R Onishi; D L Pompliano
Journal:  Biochemistry       Date:  1996-12-17       Impact factor: 3.162

9.  Large-scale preparation, purification, and crystallization of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase from Escherichia coli.

Authors:  G Auger; L Martin; J Bertrand; P Ferrari; E Fanchon; S Vaganay; Y Pétillot; J van Heijenoort; D Blanot; O Dideberg
Journal:  Protein Expr Purif       Date:  1998-06       Impact factor: 1.650

10.  Ongoing and future developments at the Universal Protein Resource.

Authors: 
Journal:  Nucleic Acids Res       Date:  2010-11-04       Impact factor: 16.971

View more
  6 in total

Review 1.  Resistance to antibiotics targeted to the bacterial cell wall.

Authors:  I Nikolaidis; S Favini-Stabile; A Dessen
Journal:  Protein Sci       Date:  2014-01-17       Impact factor: 6.725

2.  Investigation of tautomerism of 1,3,5-triazine derivative, stability, and acidity of its tautomers from density functional theory.

Authors:  Lucie Affoue Bede; Alain Kouassi Koffi; Fred-Lawson Ekozias Digre Beke; Abderrahmane Semmeq; Michael Badawi
Journal:  J Mol Model       Date:  2021-05-02       Impact factor: 1.810

3.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

4.  Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus.

Authors:  Tihomir Tomašić; Roman Sink; Nace Zidar; Anja Fic; Carlos Contreras-Martel; Andréa Dessen; Delphine Patin; Didier Blanot; Manica Müller-Premru; Stanislav Gobec; Anamarija Zega; Danijel Kikelj; Lucija Peterlin Mašič
Journal:  ACS Med Chem Lett       Date:  2012-06-27       Impact factor: 4.345

5.  Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2.

Authors:  Bo Wang; Cameron D Buchman; Liwei Li; Thomas D Hurley; Samy O Meroueh
Journal:  J Chem Inf Model       Date:  2014-06-30       Impact factor: 4.956

6.  Crystallographic Study of Peptidoglycan Biosynthesis Enzyme MurD: Domain Movement Revisited.

Authors:  Roman Šink; Miha Kotnik; Anamarija Zega; Hélène Barreteau; Stanislav Gobec; Didier Blanot; Andréa Dessen; Carlos Contreras-Martel
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.